Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HCV in sickle cell disease.

Mohamed Hassan1, Syed Hasan, Oswaldo Castro

  • 1Division of Gastroenterology, Howard University Hospital, 2041 Georgia Avenue NW, Washington, DC 20060, USA.

Journal of the National Medical Association
|October 7, 2003
PubMed
Summary

Sickle cell disease patients often get Hepatitis C Virus (HCV) from transfusions. Treating HCV in these patients is challenging, but options like hydroxyurea may help manage treatment side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dissociative amnesia with fugue following a suicide attempt: a rare clinical intersection of identity loss and suicidal ambivalence: a case report.

Frontiers in psychiatry·2026
Same author

[Corrigendum] Tumor necrosis factor‑α triggers opposing signals in head and neck squamous cell carcinoma and induces apoptosis via mitochondrial‑ and non‑mitochondrial‑dependent pathways.

International journal of oncology·2026
Same author

Stemness and Survival: CD117<sup>+</sup>/CD133<sup>+</sup> Subpopulations Sustain PI3K Signaling and Drive Imatinib Resistance in Head and Neck Mucosal Melanoma.

Cells·2026
Same author

Probing ultrafast heating and ionization dynamics in solid density plasmas with time-resolved resonant X-ray absorption and emission.

Nature communications·2026
Same author

A multicenter retrospective study of neoadjuvant chemotherapy and breast conservation rate in locally advanced breast cancer.

Discover oncology·2026
Same author

Impact of processing parameters on the interfacial bonding and properties of recycled LCS/WC-Co bilayers developed through powder metallurgy.

Scientific reports·2026

Area of Science:

  • Hematology
  • Hepatology
  • Infectious Diseases

Background:

  • Sickle cell disease (HbSS) affects many African Americans, causing chronic anemia and hemolysis.
  • Chronic transfusions in sickle cell patients increase the risk of blood-borne infections like Hepatitis C Virus (HCV).
  • HCV infection in sickle cell patients, especially with iron overload, can accelerate liver disease progression.

Purpose of the Study:

  • To review the impact of HCV infection on sickle cell disease patients.
  • To explore current and potential therapeutic strategies for managing HCV in this population.

Main Methods:

  • Literature review examining the intersection of sickle cell disease, blood transfusions, and HCV infection.
  • Analysis of treatment challenges and emerging therapeutic approaches for HCV in sickle cell patients.

Related Experiment Videos

Main Results:

  • HCV prevalence is over 10% in transfused sickle cell patients, linked to transfusion number.
  • Combined iron overload and HCV worsen liver disease progression.
  • Hydroxyurea may mitigate Ribavirin-induced hemolysis by increasing fetal hemoglobin.

Conclusions:

  • HCV poses a significant health risk to sickle cell disease patients due to transfusion exposure.
  • Managing HCV in sickle cell patients requires careful consideration of treatment efficacy and potential complications.
  • Further research, including clinical trials for treatments like Peg-interferon, is needed to optimize HCV care in sickle cell disease.